<?xml version='1.0' encoding='UTF-8'?><xml><records><record><source-app name="HighWire" version="7.x">Drupal-HighWire</source-app><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Vinall, Maria</style></author></authors><secondary-authors><author><style face="normal" font="default" size="100%">Cooper-DeHoff, Rhonda M.</style></author></secondary-authors></contributors><titles><title><style face="normal" font="default" size="100%">Emerging Evidence of Intensive Risk Factor Control to Prevent CVD in Diabetic Patients</style></title><secondary-title><style face="normal" font="default" size="100%">MD Conference Express</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2011</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2011-05-01 00:00:00</style></date></pub-dates></dates><pages><style  face="normal" font="default" size="100%">26-27</style></pages><abstract><style  face="normal" font="default" size="100%">Diabetes and hypertension share several physiological traits, and both independently predict cardiovascular morbidity and mortality. However, until recently, the systolic blood pressure targets that are currently recommended by major guidelines diabetics (&lt;130 mm Hg) had little supporting evidence from large-scale randomized trials.</style></abstract><number><style face="normal" font="default" size="100%">3</style></number><volume><style face="normal" font="default" size="100%">11</style></volume></record></records></xml>